--- title: "Pivotal Trial, Definition | MedTech Terms" description: "Definitive clinical study designed to establish safety and effectiveness for marketing authorization. Plain-English Clinical & Trials definition for MedTech tea" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/pivotal-trial#term", "name": "Pivotal Trial", "description": "A pivotal trial is the primary evidence base for a PMA, De Novo, or PMA Supplement, and increasingly for high-risk MDR submissions. Endpoints are pre-specified, statistical analysis plans are locked, and the study is typically powered for the regulatory hypothesis.", "url": "https://medtechterms.com/terms/pivotal-trial", "termCode": "pivotal-trial", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/pivotal-trial#article", "headline": "Pivotal Trial", "description": "Definitive clinical study designed to establish safety and effectiveness for marketing authorization.", "url": "https://medtechterms.com/terms/pivotal-trial", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/pivotal-trial" }, "about": { "@id": "https://medtechterms.com/terms/pivotal-trial#term" }, "articleSection": "Clinical & Trials", "inLanguage": "en", "keywords": "Pivotal Trial, Clinical & Trials, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "FDA IDE Guidance", "url": "https://www.fda.gov/medical-devices/investigational-device-exemption-ide", "publisher": { "@type": "Organization", "name": "FDA" } }, { "@type": "CreativeWork", "name": "ISO 14155 Standard Page", "url": "https://www.iso.org/standard/71690.html", "publisher": { "@type": "Organization", "name": "ISO" } }, { "@type": "CreativeWork", "name": "FDA - Clinical Trials and Human Subject Protection", "url": "https://www.fda.gov/science-research/science-and-research-special-topics/clinical-trials-and-human-subject-protection", "publisher": { "@type": "Organization", "name": "FDA" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/feasibility-study#term", "name": "Feasibility Study", "url": "https://medtechterms.com/terms/feasibility-study" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/efs#term", "name": "Early Feasibility Study", "alternateName": "EFS", "url": "https://medtechterms.com/terms/efs" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/ide#term", "name": "Investigational Device Exemption", "alternateName": "IDE", "url": "https://medtechterms.com/terms/ide" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Clinical & Trials", "item": "https://medtechterms.com/terms?cat=Clinical%20%26%20Trials" }, { "@type": "ListItem", "position": 4, "name": "Pivotal Trial", "item": "https://medtechterms.com/terms/pivotal-trial" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/pivotal-trial#faq", "mainEntity": [ { "@type": "Question", "name": "What distinguishes a pivotal trial from other clinical studies?", "acceptedAnswer": { "@type": "Answer", "text": "A pivotal trial is typically a large, well-controlled study intended to provide definitive evidence of a device's safety and effectiveness for regulatory approval, unlike earlier-phase studies that explore feasibility or gather preliminary data." } }, { "@type": "Question", "name": "How are endpoints determined for a pivotal trial?", "acceptedAnswer": { "@type": "Answer", "text": "Endpoints are predefined measures of a device's performance or patient outcomes that are statistically analyzed to assess its safety and effectiveness. These are critical for demonstrating the study's primary hypothesis." } }, { "@type": "Question", "name": "Can a pivotal trial be used for CE marking under the EU MDR?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, for high-risk devices, robust clinical data from pivotal trials is often required to demonstrate conformity with the General Safety and Performance Requirements (GSPRs) of the EU MDR, supporting the CE marking process." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Clinical & Trials](/terms?cat=Clinical%20%26%20Trials) 6. / 7. Pivotal Trial [All terms](/terms) Clinical & Trials [Clinical Evidence](/ecosystems/clinical-evidence)[Startup Lifecycle](/ecosystems/startup-lifecycle) # Pivotal Trial Definitive clinical study designed to establish safety and effectiveness for marketing authorization. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition A pivotal trial is the primary evidence base for a [PMA](/terms/pma), [De Novo](/terms/de-novo), or PMA Supplement, and increasingly for high-risk [MDR](/terms/mdr-reporting) submissions. Endpoints are pre-specified, statistical analysis plans are locked, and the study is typically powered for the regulatory hypothesis. What the regulation says Under FDA regulations, a pivotal trial provides the definitive clinical evidence required for [premarket approval](/terms/pma) (PMA) of Class III devices, as outlined in 21 CFR Part 814. These trials are designed to demonstrate the safety and effectiveness of a device for its [intended use](/terms/intended-use). For CE marking under the EU [MDR](/terms/mdr-reporting), similar rigorous clinical evidence, often from pivotal studies, is necessary for high-risk devices, as specified in Annex I, Chapter II, Section 6. ## What this means in practice Often preceded by feasibility and [EFS](/terms/efs) studies and followed by post-approval/ [PMCF](/terms/pmcf) studies. ## Examples - A medical device manufacturer conducts a randomized controlled pivotal trial to compare the effectiveness of a novel cardiac stent against an already approved device for reducing restenosis rates. - For a new diagnostic imaging system, a pivotal trial enrolls a large cohort of patients to demonstrate its accuracy and reliability in detecting a specific medical condition compared to current diagnostic standards. - A company developing an implantable neurostimulation device performs a pivotal study to show its long-term safety and efficacy in managing chronic pain, with pre-specified outcome measures related to pain reduction and quality of life. Common pitfalls - • A common pitfall is conducting a pivotal trial without first establishing a clear statistical analysis plan, which can lead to questions about data integrity and interpretation. - • Failing to adequately power a pivotal trial for its primary endpoints can result in inconclusive results, necessitating additional studies. - • Misinterpreting preliminary data from feasibility or early feasibility studies as sufficient for regulatory submission is a frequent mistake. - • Not addressing potential biases in patient selection or data collection during the trial design phase can undermine the validity of the results. - • Neglecting to consider the long-term follow-up requirements for certain devices can lead to incomplete data at the time of submission. ## Frequently asked questions What distinguishes a pivotal trial from other clinical studies? A pivotal trial is typically a large, well-controlled study intended to provide definitive evidence of a device's safety and effectiveness for regulatory approval, unlike earlier-phase studies that explore feasibility or gather preliminary data. How are endpoints determined for a pivotal trial? Can a pivotal trial be used for CE marking under the EU MDR? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Clinical & Trials Feasibility Study Small clinical study evaluating initial safety, usability, and design parameters of an investigational device. ](/terms/feasibility-study)[ Clinical & Trials Investigational Device Exemption(IDE) FDA authorization to use an investigational device in a clinical study. ](/terms/ide)[ Clinical & Trials Early Feasibility Study(EFS) FDA program enabling early human evaluation of novel devices with limited preclinical data and iterative design. ](/terms/efs) ### Clinical Trials & Evidence · From this learning path [ Clinical & Trials Adaptive Trial Design Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data. Adjacent lesson ](/terms/adaptive-trial?from=clinical-trials-and-evidence)[ Clinical & Trials Adverse Event(AE) Any untoward medical occurrence in a subject, whether or not related to the device. ](/terms/adverse-event?from=clinical-trials-and-evidence)[ Clinical & Trials Clinical Evaluation Report(CER) Documented assessment of clinical data demonstrating EU MDR conformity for a device. ](/terms/cer?from=clinical-trials-and-evidence)[ Clinical & Trials IDE Annual Progress Report Annual report sponsors must submit to FDA summarizing the progress of an approved IDE study, including enrollment, deviations, and adverse events. ](/terms/ide-annual-report?from=clinical-trials-and-evidence) ### More in Clinical & Trials · Same category [ Clinical & Trials IDE Supplement Amendment to an approved Investigational Device Exemption for protocol or device changes. ](/terms/ide-supplement) Cited by Where this term appears across MedTech Terms. Learning paths (1) - [Clinical Trials & Evidence](/paths/clinical-trials-and-evidence)Lesson 14 of 18 Ecosystems (2) - [Clinical Evidence](/ecosystems/clinical-evidence) - [Startup Lifecycle](/ecosystems/startup-lifecycle) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 FDA· 2 ISO· 1 1. [1 FDA IDE Guidance Verified FDA · fda.gov ](https://www.fda.gov/medical-devices/investigational-device-exemption-ide) 2. [2 ISO 14155 Standard Page Verified ISO · iso.org ](https://www.iso.org/standard/71690.html) 3. [3 FDA - Clinical Trials and Human Subject Protection Verified FDA · fda.gov ](https://www.fda.gov/science-research/science-and-research-special-topics/clinical-trials-and-human-subject-protection) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Clinical evidence intersecting with device security? We support clinical-stage MedTech teams whose investigational devices touch patient data or hospital networks. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Clinical & Trials Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=pivotal-trial) Learn in 60 seconds Card Lesson Quiz Definitive clinical study designed to establish safety and effectiveness for marketing authorization. - · Often preceded by feasibility and EFS studies and followed by post-approval/PMCF studies. - · Endpoints are pre-specified, statistical analysis plans are locked, and the study is typically powered for the regulatory hypothesis. Remember this Watch out: A common pitfall is conducting a pivotal trial without first establishing a clear statistical analysis plan, which can lead to questions about data integrity and interpretation. Related terms - [Feasibility Study ](/terms/feasibility-study) - [Early Feasibility Study(EFS) ](/terms/efs) - [Investigational Device Exemption(IDE) ](/terms/ide) You may also need Auto-suggested from Clinical & Trials and shared keywords. - [Primary and Secondary Endpoints ](/terms/primary-secondary-endpoint) - [Investigator-Initiated Trial(IIT) ](/terms/investigator-initiated-trial) - [Sample Size and Statistical Power ](/terms/sample-size-power) - [Contract Research Organization(CRO) ](/terms/cro) - [Electronic Data Capture(EDC) ](/terms/edc) - [Pragmatic Trial ](/terms/pragmatic-trial) [All Clinical & Trials terms](/terms?cat=Clinical%20%26%20Trials) From the Blue Goat network Related resources and services on this topic. - [ MedTech Launchpad MedTech funding rounds, accelerators, and launch resources. ](https://medtechlaunchguide.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)